{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:59:38Z","timestamp":1790362778167,"version":"4.1.0"},"reference-count":102,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2014.0301","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:19:26Z","timestamp":1525252766000},"source":"Crossref","is-referenced-by-count":16,"title":["Not All Acne Is Acne Vulgaris"],"prefix":"10.3238","author":[{"given":"Harald P.","family":"Gollnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2014,4,25]]},"reference":[{"key":"10.3238\/arztebl.2014.0301_ref1","doi-asserted-by":"crossref","unstructured":"Nast A, Bayerl C, Borelli C, et al.: S2k-Leitlinie zur Therapie der Akne. J Dtsch Dermatol Ges 2010; 8(Suppl 2): 1\u201359.","DOI":"10.1111\/j.1610-0387.2010.07466.x"},{"key":"10.3238\/arztebl.2014.0301_ref2","doi-asserted-by":"crossref","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, et al.: European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26(Suppl 1): 1\u201329.","DOI":"10.1111\/j.1468-3083.2011.04374.x"},{"key":"10.3238\/arztebl.2014.0301_ref3","doi-asserted-by":"crossref","unstructured":"Zouboulis CC: Acne and sebaceous gland function. Clin Dermatol 2004; 22: 360\u20136.","DOI":"10.1016\/j.clindermatol.2004.03.004"},{"key":"10.3238\/arztebl.2014.0301_ref4","doi-asserted-by":"crossref","unstructured":"Zouboulis CC, Eady A, Philpott M, et al.: What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143\u201352.","DOI":"10.1111\/j.0906-6705.2005.0285a.x"},{"key":"10.3238\/arztebl.2014.0301_ref5","doi-asserted-by":"crossref","unstructured":"Kurokawa I, Danby FW, Ju Q, et al.: New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009; 18: 821\u201332.","DOI":"10.1111\/j.1600-0625.2009.00890.x"},{"key":"10.3238\/arztebl.2014.0301_ref6","doi-asserted-by":"crossref","unstructured":"Zouboulis CC: Moderne Aspekte der Aknepathogenese. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 7\u201314.","DOI":"10.1111\/j.1610-0387.2009.07168.x"},{"key":"10.3238\/arztebl.2014.0301_ref7","doi-asserted-by":"crossref","unstructured":"Gollnick HP, Finlay AY, Shear N; Global Alliance to Improve Outcomes in Acne: Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol 2008; 9: 279\u201384.","DOI":"10.2165\/00128071-200809050-00001"},{"key":"10.3238\/arztebl.2014.0301_ref8","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer T, Kahl C, Rzany B: Epidemiologie der Akne. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 4\u20136.","DOI":"10.1111\/j.1610-0387.2009.07167.x"},{"key":"10.3238\/arztebl.2014.0301_ref9","doi-asserted-by":"crossref","unstructured":"Schaefer I, Rustenbach SJ, Zimmer L, Augustin M: Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169\u201372.","DOI":"10.1159\/000136656"},{"key":"10.3238\/arztebl.2014.0301_ref10","doi-asserted-by":"crossref","unstructured":"Ghodsi SZ, Orawa H, Zouboulis CC: Prevalence, severity and severity risk factors of acne in high school pupils: A community-based study. J Invest Dermatol 2009; 129: 2136\u201341.","DOI":"10.1038\/jid.2009.47"},{"key":"10.3238\/arztebl.2014.0301_ref11","doi-asserted-by":"crossref","unstructured":"Niemeier V, Kupfer J, Gieler U: Akne vulgaris \u2013 Psychosomatische Aspekte. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 95\u2013104.","DOI":"10.1111\/j.1610-0387.2006.06110_suppx.x"},{"key":"10.3238\/arztebl.2014.0301_ref12","doi-asserted-by":"crossref","unstructured":"Radtke MA, Sch\u00e4fer I, Augustin M: Pharmako\u00f6konomie der Akne \u2013 Bewertung von Nutzen und Wirtschaftlichkeit. J Dtsch Dermatol Ges 2010; 8 (Suppl 1): 1055\u2013114.","DOI":"10.1111\/j.1610-0387.2009.07175.x"},{"key":"10.3238\/arztebl.2014.0301_ref13","doi-asserted-by":"crossref","unstructured":"Jemec GB, Linneberg A, Nielsen NH, Frolund L, Madsen F, Jorgensen T: Have oral contraceptives reduced the prevalence of acne? A population-based study of acne vulgaris, tobacco smoking and oral contraceptives. Dermatology 2002; 204: 179\u201384.","DOI":"10.1159\/000057878"},{"key":"10.3238\/arztebl.2014.0301_ref14","doi-asserted-by":"crossref","unstructured":"Zouboulis CC: Acne vulgaris \u2013 Rolle der Hormone. Hautarzt 2010; 61: 107\u201314","DOI":"10.1007\/s00105-009-1830-1"},{"key":"10.3238\/arztebl.2014.0301_ref15","doi-asserted-by":"crossref","unstructured":"Thielitz A, Gollnick H: Overview of new therapeutic developments for acne. Expert Rev Dermatol 2009; 4: 55\u201365.","DOI":"10.1586\/17469872.4.1.55"},{"key":"10.3238\/arztebl.2014.0301_ref16","doi-asserted-by":"crossref","unstructured":"Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC: Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol 2009; 160: 345\u201352.","DOI":"10.1111\/j.1365-2133.2008.08959.x"},{"key":"10.3238\/arztebl.2014.0301_ref17","doi-asserted-by":"crossref","unstructured":"Fluhr JW, Degitz K: Antibiotika, Azelains\u00e4ure und Benzoylperoxid in der topische Aknetherapie. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 24\u201330.","DOI":"10.1111\/j.1610-0387.2009.07169.x"},{"key":"10.3238\/arztebl.2014.0301_ref18","doi-asserted-by":"crossref","unstructured":"Thielitz A, Abdel-Naser MB, Fluhr JW, Zouboulis CC, Gollnick H: Topische Retinoide bei Akne \u2013 eine evidenzbasierte \u00dcbersicht. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 15\u201323.","DOI":"10.1111\/j.1610-0387.2008.06741_suppx.x"},{"key":"10.3238\/arztebl.2014.0301_ref19","doi-asserted-by":"crossref","unstructured":"Ochsendorf F: Systemische Antibiotika zur Behandlung der Acne vulgaris. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 31\u201346.","DOI":"10.1111\/j.1610-0387.2006.06053_suppx.x"},{"key":"10.3238\/arztebl.2014.0301_ref20","doi-asserted-by":"crossref","unstructured":"Zouboulis CC, Rabe T: Hormonelle Antiandrogene in der Aknetherapie. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 60\u201374.","DOI":"10.1111\/j.1610-0387.2009.07171.x"},{"key":"10.3238\/arztebl.2014.0301_ref21","doi-asserted-by":"crossref","unstructured":"Degitz K, Plewig G, Gollnick H: Erg\u00e4nzende Verfahren in der Aknetherapie \u2013 Aktualisierung 2010. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 75\u201380.","DOI":"10.1111\/j.1610-0387.2005.04087_suppx.x"},{"key":"10.3238\/arztebl.2014.0301_ref22","doi-asserted-by":"crossref","unstructured":"Bayerl C, Degitz K, Meigel E, Kerscher M: Adjuvante dermatokosmetische Aknetherapie. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 89\u201394.","DOI":"10.1111\/j.1610-0387.2009.07174.x"},{"key":"10.3238\/arztebl.2014.0301_ref23","doi-asserted-by":"crossref","unstructured":"Jansen T, Podda M: Therapie der Aknenarben. J Dtsch Dermatol Ges 2010; 8(Suppl 1): 81\u20138.","DOI":"10.1111\/j.1610-0387.2009.07173.x"},{"key":"10.3238\/arztebl.2014.0301_ref24","doi-asserted-by":"crossref","unstructured":"Ganceviciene R, Zouboulis CC: Isotretinoin: state of the art treatment for acne vulgaris. Expert Rev Dermatol 2007; 2: 693\u2013706.","DOI":"10.1586\/17469872.2.6.693"},{"key":"10.3238\/arztebl.2014.0301_ref25","doi-asserted-by":"crossref","unstructured":"Layton AM, Dreno B, Gollnick HPM, Zouboulis CC: A review of the European directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 2006; 20: 773\u20136.","DOI":"10.1111\/j.1468-3083.2006.01671.x"},{"key":"10.3238\/arztebl.2014.0301_ref26","doi-asserted-by":"crossref","unstructured":"Marqueling AL, Zane LT: Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 2007; 26: 210\u201320.","DOI":"10.1016\/j.sder.2008.03.005"},{"key":"10.3238\/arztebl.2014.0301_ref27","unstructured":"Arzneimittelkommission der Deutschen \u00c4rzteschaft: Isotretinoin und chronisch-entz\u00fcndliche Darmerkrankung. Dtsch Arztebl 2012; 109: A-1044."},{"key":"10.3238\/arztebl.2014.0301_ref28","doi-asserted-by":"crossref","unstructured":"Franzke N, Zimmer L, Sch\u00e4fer I, Radermacher C, Kresken J, Augustin M: Quality of medical care of patients with acne vulgaris in Germany \u2013 nationwide survey of pharmacy clients. J Dtsch Dermatol Ges 2009; 7: 1060\u20133.","DOI":"10.1111\/j.1610-0387.2009.07155.x"},{"key":"10.3238\/arztebl.2014.0301_ref29","doi-asserted-by":"crossref","unstructured":"Zouboulis CC: Moderne Aspekte der Aknepathogenese. Akt Dermatol 2006; 32: 296\u2013302.","DOI":"10.1055\/s-2006-944576"},{"key":"10.3238\/arztebl.2014.0301_ref30","doi-asserted-by":"crossref","unstructured":"Chen W, Obermayer-Pietsch B, Hong J-B, et al.: Acne-associated syndromes: Models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol 2011; 25: 637\u201346.","DOI":"10.1111\/j.1468-3083.2010.03937.x"},{"key":"10.3238\/arztebl.2014.0301_ref31","doi-asserted-by":"crossref","unstructured":"Bickers DR, Lim HW, Margolis D, et al.: The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006; 55: 490\u2013500.","DOI":"10.1016\/j.jaad.2006.05.048"},{"key":"10.3238\/arztebl.2014.0301_ref32","doi-asserted-by":"crossref","unstructured":"Bechelli L, Haddad N, Pimenta W, et al.: Epidemiological survey of skin diseases in schoolchildren living in the Purus Valley (Acre State, Amazonia, Brazil). Dermatologica 1981; 163: 78\u201393.","DOI":"10.1159\/000250144"},{"key":"10.3238\/arztebl.2014.0301_ref33","doi-asserted-by":"crossref","unstructured":"Burton JL, Cunliffe WJ, Stafford I, et al.: The prevalence of acne vulgaris in adolescence Br J Dermatol 1971; 85: 119\u201326","DOI":"10.1111\/j.1365-2133.1971.tb07195.x"},{"key":"10.3238\/arztebl.2014.0301_ref34","doi-asserted-by":"crossref","unstructured":"Bloch B: Metabolism, endocrine glands and skin diseases, with special reference to acne vulgaris and xanthoma. Br J Dermatol 1931; 43: 77\u201387.","DOI":"10.1111\/j.1365-2133.1931.tb09468.x"},{"key":"10.3238\/arztebl.2014.0301_ref35","unstructured":"Hellgren L: A preliminary report of the prevalence of seborrhoeic dermatitis, acne vulgaris and warts in the county of Skaraborg in Sweden. Acta Derm Venerel (Stockh) 1963; 43: 502\u20139."},{"key":"10.3238\/arztebl.2014.0301_ref36","doi-asserted-by":"crossref","unstructured":"Larsson PA, Liden S: Prevalence of skin diseases among adolescents 12\u201316 years of age. Acta Derm Venereol 1980: 60: 415\u201323","DOI":"10.2340\/0001555560415423"},{"key":"10.3238\/arztebl.2014.0301_ref37","doi-asserted-by":"crossref","unstructured":"Rea J, Newhouse M, Halil T: Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 1976; 30: 107\u201314","DOI":"10.1136\/jech.30.2.107"},{"key":"10.3238\/arztebl.2014.0301_ref38","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer T, Nienhaus A, Vieluf D, Berger J, Ring J: Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145: 100\u20134","DOI":"10.1046\/j.1365-2133.2001.04290.x"},{"key":"10.3238\/arztebl.2014.0301_ref39","doi-asserted-by":"crossref","unstructured":"Dr\u00e9no B, Layton A, Zouboulis CC, et al.: Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol, 2013 Sep; 27: 1063\u201370","DOI":"10.1111\/jdv.12061"},{"key":"10.3238\/arztebl.2014.0301_ref40","doi-asserted-by":"crossref","unstructured":"Knaggs HE, Wood EJ, Rizer RL, Mills OH: Post-adolescent acne. Int J Cosmet Sci 2004; 26: 129\u201338 MEDLINE","DOI":"10.1111\/j.1467-2494.2004.00210.x"},{"key":"10.3238\/arztebl.2014.0301_ref41","doi-asserted-by":"crossref","unstructured":"Goulden V, McGeown CH, Cunliffe WJ: The familial risk of adult acne: a comparison between first\u2013degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 14: 297.","DOI":"10.1046\/j.1365-2133.1999.02979.x"},{"key":"10.3238\/arztebl.2014.0301_ref42","doi-asserted-by":"crossref","unstructured":"Dumont-Wallon G, Dr\u00e9no B: Acn\u00e9 de la femme de plus de 25 ans: sp\u00e9cifique par sa clinique et les facteurs favorisants: \u00c9tude r\u00e9trospective de 79 femmes. Presse Med 2008; 37: 585\u201391 MEDLINE","DOI":"10.1016\/j.lpm.2007.07.014"},{"key":"10.3238\/arztebl.2014.0301_ref43","doi-asserted-by":"crossref","unstructured":"Shen Y, Wang T, Zhou C, et al.: Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities. Acta Derm Venereol 2012; 92: 40\u20134","DOI":"10.2340\/00015555-1164"},{"key":"10.3238\/arztebl.2014.0301_ref44","doi-asserted-by":"crossref","unstructured":"Collier CN, Harper JC, Cafardi JA, et al.: The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56\u20139 MEDLINE","DOI":"10.1016\/j.jaad.2007.06.045"},{"key":"10.3238\/arztebl.2014.0301_ref45","doi-asserted-by":"crossref","unstructured":"Walton S, Wyatt EH, Cunliffe WJ: Genetic control of sebum excretion and acne\u2014a twin study. Br J Dermatol 1988; 118: 393\u20136","DOI":"10.1111\/j.1365-2133.1988.tb02433.x"},{"key":"10.3238\/arztebl.2014.0301_ref46","doi-asserted-by":"crossref","unstructured":"Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD: The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002; 119: 1317\u201322","DOI":"10.1046\/j.1523-1747.2002.19621.x"},{"key":"10.3238\/arztebl.2014.0301_ref47","doi-asserted-by":"crossref","unstructured":"Galobardes B, Smith GD, Jeffreys M, Kinra S, McCarron P: Acne in adolescence and cause-specific mortality: Lower coronary heart disease but higher prostate cancer mortality. The Glasgow Alumni Cohort Study. Am J Epidemiol 2005; 161: 1094\u2013101","DOI":"10.1093\/aje\/kwi147"},{"key":"10.3238\/arztebl.2014.0301_ref48","doi-asserted-by":"crossref","unstructured":"Norris JF, Cunliffe WJ: A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988; 118: 651\u20139","DOI":"10.1111\/j.1365-2133.1988.tb02566.x"},{"key":"10.3238\/arztebl.2014.0301_ref49","doi-asserted-by":"crossref","unstructured":"Cunliffe WJ, Holland DB, Clark SM, Stables GI: Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 1084\u201391","DOI":"10.1046\/j.1365-2133.2000.03531.x"},{"key":"10.3238\/arztebl.2014.0301_ref50","doi-asserted-by":"crossref","unstructured":"Xu Y, Yang L, Yang T, Xiang M, Huang E, Lian X: Expression pattern of cyclooxygenase-2 in normal rat epidermis and pilosebaceous unit during hair cycle. Acta Histochem Cytochem 2008; 41: 157\u201363","DOI":"10.1267\/ahc.08024"},{"key":"10.3238\/arztebl.2014.0301_ref51","doi-asserted-by":"crossref","unstructured":"Jeremy AHT, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ: Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121: 20\u20137","DOI":"10.1046\/j.1523-1747.2003.12321.x"},{"key":"10.3238\/arztebl.2014.0301_ref52","doi-asserted-by":"crossref","unstructured":"Zouboulis CC: Is acne vulgaris a genuine inflammatory disease? Dermatology 2001; 203: 277\u20139","DOI":"10.1159\/000051771"},{"key":"10.3238\/arztebl.2014.0301_ref53","doi-asserted-by":"crossref","unstructured":"Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ: Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992; 98: 895\u2013901","DOI":"10.1111\/1523-1747.ep12460324"},{"key":"10.3238\/arztebl.2014.0301_ref54","doi-asserted-by":"crossref","unstructured":"Pochi PE, Strauss JS: Sebaceous gland response in man to the administration of testosterone, D4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol 1969; 52: 32\u20136","DOI":"10.1038\/jid.1969.4"},{"key":"10.3238\/arztebl.2014.0301_ref55","doi-asserted-by":"crossref","unstructured":"Chen W, Yang CC, Liao CY, et al.: Expression of sex-determining genes in human sebaceous glands and their possible roles in pathogenesis of acne. J Eur Acad Dermatol Venereol 2006; 20: 846\u201352","DOI":"10.1111\/j.1468-3083.2006.01663.x"},{"key":"10.3238\/arztebl.2014.0301_ref56","unstructured":"Cunliffe W, Forster R: Androgen control of the pilosebaceous duct? Brit J Dermatol 1987; 116: 449."},{"key":"10.3238\/arztebl.2014.0301_ref57","unstructured":"Zouboulis CC: The sebaceous gland in adolescent age. Eur J Ped Dermatol 2008; 18: 150\u20134."},{"key":"10.3238\/arztebl.2014.0301_ref58","doi-asserted-by":"crossref","unstructured":"Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J: Acne vulgaris in premenarchal girls. Arch Dermatol 1994; 130: 308\u201314","DOI":"10.1001\/archderm.130.3.308"},{"key":"10.3238\/arztebl.2014.0301_ref59","doi-asserted-by":"crossref","unstructured":"Stewart ME, Downing DT, Cook JS, Hansen JR, Strauss JS: Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992; 128: 1345\u20138","DOI":"10.1001\/archderm.128.10.1345"},{"key":"10.3238\/arztebl.2014.0301_ref60","doi-asserted-by":"crossref","unstructured":"Marynick SP, Chakmajian ZH, McCaffree DL, Herdon JH: Androgen excess in cystic acne. N Engl J Med 1983; 308: 981\u20136","DOI":"10.1056\/NEJM198304283081701"},{"key":"10.3238\/arztebl.2014.0301_ref61","doi-asserted-by":"crossref","unstructured":"Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P: The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metabol 1993; 76: 524\u20138","DOI":"10.1210\/jcem.76.2.8381804"},{"key":"10.3238\/arztebl.2014.0301_ref62","doi-asserted-by":"crossref","unstructured":"Alestas T, Ganceviciene R, Fimmel S, M\u00fcller-Decker K, Zouboulis CC: Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 2006; 84: 75\u201387","DOI":"10.1007\/s00109-005-0715-8"},{"key":"10.3238\/arztebl.2014.0301_ref63","doi-asserted-by":"crossref","unstructured":"Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M: Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp Dermatol 2002; 11: 241\u20137","DOI":"10.1034\/j.1600-0625.2002.110307.x"},{"key":"10.3238\/arztebl.2014.0301_ref64","doi-asserted-by":"crossref","unstructured":"Alesci S, Bornstein SR: Neuroimmunoregulation of androgens in the adrenal gland and the skin. Horm Res 2000; 54: 281\u20136","DOI":"10.1159\/000053272"},{"key":"10.3238\/arztebl.2014.0301_ref65","doi-asserted-by":"crossref","unstructured":"Slominski AT, Botchkarev V, Choudhry M, et al.: Cutaneous expression of CRH and CRH-R. Is there a \u201eskin stress response system?\u201c. Ann N Y Acad Sci 1999; 885: 287\u2013311","DOI":"10.1111\/j.1749-6632.1999.tb08686.x"},{"key":"10.3238\/arztebl.2014.0301_ref66","doi-asserted-by":"crossref","unstructured":"Zouboulis CC: The human skin as a hormone target and an endocrine gland. Hormones 2004; 3: 9\u201326","DOI":"10.14310\/horm.2002.11109"},{"key":"10.3238\/arztebl.2014.0301_ref67","doi-asserted-by":"crossref","unstructured":"Letawe C, Boone M, Pierard GE: Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 1998; 23: 56\u20138","DOI":"10.1046\/j.1365-2230.1998.00315.x"},{"key":"10.3238\/arztebl.2014.0301_ref68","doi-asserted-by":"crossref","unstructured":"Melnik BC: Diet in acne: further evidence for the role of nutrient signalling in acne pathogenesis. Acta Derm Venereol 2012; 92: 228\u201331","DOI":"10.2340\/00015555-1358"},{"key":"10.3238\/arztebl.2014.0301_ref69","doi-asserted-by":"crossref","unstructured":"Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J: Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138: 1584\u201390","DOI":"10.1001\/archderm.138.12.1584"},{"key":"10.3238\/arztebl.2014.0301_ref70","doi-asserted-by":"crossref","unstructured":"Smith RN, Mann NJ, Braue A, M\u00e4kel\u00e4inen H, Varigos GA: A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr 2007; 86: 107\u201315","DOI":"10.1093\/ajcn\/86.1.107"},{"key":"10.3238\/arztebl.2014.0301_ref71","doi-asserted-by":"crossref","unstructured":"Adebamowo CA, Spiegelman D, Berkey CS, et al.: Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008; 58: 787\u201393","DOI":"10.1016\/j.jaad.2007.08.049"},{"key":"10.3238\/arztebl.2014.0301_ref72","doi-asserted-by":"crossref","unstructured":"Firooz A, Sarhangnejad R, Davoudi SM, Nassiri-Kashani M: Acne and smoking: is there a relationship? BMC Dermatol 2005; 5: 2","DOI":"10.1186\/1471-5945-5-2"},{"key":"10.3238\/arztebl.2014.0301_ref73","doi-asserted-by":"crossref","unstructured":"Klaz I, Kochba I, Shohat T, Zarka S, Brenner S: Severe acne vulgaris and tobacco smoking in young men. J Invest Dermatol 2006; 126: 1749\u201352","DOI":"10.1038\/sj.jid.5700326"},{"key":"10.3238\/arztebl.2014.0301_ref74","doi-asserted-by":"crossref","unstructured":"Kim J, Ochoa MT, Krutzik SR, et al.: Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169: 1535\u201341","DOI":"10.4049\/jimmunol.169.3.1535"},{"key":"10.3238\/arztebl.2014.0301_ref75","doi-asserted-by":"crossref","unstructured":"Pivarcsi A, Bodai L, Rethi B, et al.: Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15: 721\u201330","DOI":"10.1093\/intimm\/dxg068"},{"key":"10.3238\/arztebl.2014.0301_ref76","doi-asserted-by":"crossref","unstructured":"Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E, Kem\u00e9ny L: Distinct strains of Propionibacterium acnes induces selective human b\u2013defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J Invest Dermatol 2005; 124: 931\u20138","DOI":"10.1111\/j.0022-202X.2005.23705.x"},{"key":"10.3238\/arztebl.2014.0301_ref77","doi-asserted-by":"crossref","unstructured":"Alexeyev O, Lundskog B, Ganceviciene R, et al.: Pattern of tissue invasion by Propionibacterium acnes in acne vulgaris. J Derm Sci 2012; 67: 63\u20136","DOI":"10.1016\/j.jdermsci.2012.03.004"},{"key":"10.3238\/arztebl.2014.0301_ref78","doi-asserted-by":"crossref","unstructured":"Jahns AC, Lundskog B, Ganceviciene R, et al.: An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case control study. Br J Dermatol 2012; 167: 50\u20138","DOI":"10.1111\/j.1365-2133.2012.10897.x"},{"key":"10.3238\/arztebl.2014.0301_ref79","doi-asserted-by":"crossref","unstructured":"St\u00fcttgen G: Zur Lokalbehandlung von Keratosen mit Vitamin A-S\u00e4ure. Dermatologica 1962; 124: 65\u201380","DOI":"10.1159\/000255058"},{"key":"10.3238\/arztebl.2014.0301_ref80","doi-asserted-by":"crossref","unstructured":"Schumacher A, St\u00fcttgen G: Vitamin-A-S\u00e4ure bei Hyerkeratosen, epithelialen Tumoren und Akne. Deutsch Med Wschr 1971; 96: 1547\u201351","DOI":"10.1055\/s-0028-1110177"},{"key":"10.3238\/arztebl.2014.0301_ref81","doi-asserted-by":"crossref","unstructured":"Peck GL, Olsen TG, Yoder FW, et al.: Prolonged remissions of cystic and conglobate acne with 13-cis retinoic acid. N Engl J Med 1979; 300: 329\u201333","DOI":"10.1056\/NEJM197902153000701"},{"key":"10.3238\/arztebl.2014.0301_ref82","doi-asserted-by":"crossref","unstructured":"Sapadin AN, Fleischmajer R: Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006; 54: 258\u201365","DOI":"10.1016\/j.jaad.2005.10.004"},{"key":"10.3238\/arztebl.2014.0301_ref83","doi-asserted-by":"crossref","unstructured":"Zouboulis CC: The truth behind this undeniable efficacy\u2014recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology 2006; 212: 99\u2013100","DOI":"10.1159\/000090646"},{"key":"10.3238\/arztebl.2014.0301_ref84","doi-asserted-by":"crossref","unstructured":"Orfanos CE, Zouboulis CC: Oral retinoids in the treatment of seborrhoea and acne. Dermatology 1998; 196: 140\u20137","DOI":"10.1159\/000017848"},{"key":"10.3238\/arztebl.2014.0301_ref85","doi-asserted-by":"crossref","unstructured":"Zouboulis CC, Piquero-Martin J: Update and future of systemic acne treatment. Dermatology 2003; 206: 37\u201353.e74.","DOI":"10.1159\/000067821"},{"key":"10.3238\/arztebl.2014.0301_ref86","doi-asserted-by":"crossref","unstructured":"Goldstein JA, Comite H, Mescon H, Pochi PE: Isotretinoin in the treatment of acne: histologic changes, sebum production, and clinical observations. Arch Dermatol 1982; 118: 555\u20138","DOI":"10.1001\/archderm.118.8.555"},{"key":"10.3238\/arztebl.2014.0301_ref87","doi-asserted-by":"crossref","unstructured":"Jones DH, King K, Miller AJ, Cunliffe WJ: A dose-response study of 13-cis-retinoic acid in acne vulgaris. Br J Dermatol 1983;108:333\u201343","DOI":"10.1111\/j.1365-2133.1983.tb03973.x"},{"key":"10.3238\/arztebl.2014.0301_ref88","doi-asserted-by":"crossref","unstructured":"Hennes R, Mack A, Schell H, Vogt HJ: 13-cis-retinoic acid in conglobate acne. A follow-up study of 14 trial centers. Arch Dermatol Res 1984; 276: 209\u201315","DOI":"10.1007\/BF00414230"},{"key":"10.3238\/arztebl.2014.0301_ref89","doi-asserted-by":"crossref","unstructured":"Harms M, Masouye I, Radeff B: The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Dermatologica. 1986; 172: 148\u201353","DOI":"10.1159\/000249320"},{"key":"10.3238\/arztebl.2014.0301_ref90","doi-asserted-by":"crossref","unstructured":"Cunliffe WJ, Norris JF: Isotretinoin \u2013 an explanation for its long-term benefit. Dermatologica 1987; 175(suppl 1): 133\u20137","DOI":"10.1159\/000248869"},{"key":"10.3238\/arztebl.2014.0301_ref91","doi-asserted-by":"crossref","unstructured":"Chivot M, Midoun H: Isotretinoin and acne\u2014a study of relapses. Dermatologica 1990; 180: 240\u20133","DOI":"10.1159\/000248038"},{"key":"10.3238\/arztebl.2014.0301_ref92","doi-asserted-by":"crossref","unstructured":"Layton AM, Knaggs H, Taylor J, Cunliffe WJ: Isotretinoin for acne vulgaris\u201410 years later: A safe and successful treatment. Br J Dermatol 1993; 129: 292\u20136","DOI":"10.1111\/j.1365-2133.1993.tb11849.x"},{"key":"10.3238\/arztebl.2014.0301_ref93","doi-asserted-by":"crossref","unstructured":"Lehucher-Ceyrac D, Weber-Buisset MJ: Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology 1993; 186: 123\u20138","DOI":"10.1159\/000247322"},{"key":"10.3238\/arztebl.2014.0301_ref94","doi-asserted-by":"crossref","unstructured":"Lehucher-Ceyrac D, de La Salmoniere P, Chastang C, Morel P: Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients. Dermatology 1999; 198: 278\u201383","DOI":"10.1159\/000018130"},{"key":"10.3238\/arztebl.2014.0301_ref95","doi-asserted-by":"crossref","unstructured":"Shahidullah M, Tham SN, Goh CL: Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore. Int J Dermatol 1994; 33: 60\u20133","DOI":"10.1111\/j.1365-4362.1994.tb01500.x"},{"key":"10.3238\/arztebl.2014.0301_ref96","doi-asserted-by":"crossref","unstructured":"Goulden V, Clark SM, McGeown C, Cunliffe WJ: Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997; 137: 106\u20138","DOI":"10.1111\/j.1365-2133.1997.tb03710.x"},{"key":"10.3238\/arztebl.2014.0301_ref97","doi-asserted-by":"crossref","unstructured":"Qu\u00e9reux G, Volteau C, N\u2019Guyen JM, Dr\u00e9no B: Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology 2006; 212: 168\u201376","DOI":"10.1159\/000090658"},{"key":"10.3238\/arztebl.2014.0301_ref98","doi-asserted-by":"crossref","unstructured":"Karadag AS, Bilgili SG, Selvi Y, et al.: Effects of isotretinoin treatment on general psychiatric symptoms, quality of life and social phobia in acne vulgaris patients. J Eur Acad Dermatol Venereol 2013; 27: 260\u20131","DOI":"10.1111\/j.1468-3083.2011.04439.x"},{"key":"10.3238\/arztebl.2014.0301_ref99","doi-asserted-by":"crossref","unstructured":"Rubinow DR, Peck GL, Squillace KM, Gantt GG: Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17: 25\u201332","DOI":"10.1016\/S0190-9622(87)70166-2"},{"key":"10.3238\/arztebl.2014.0301_ref100","doi-asserted-by":"crossref","unstructured":"Bernstein CN, Nugent Z, Longobardi T, Blanchard JF: Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol 2009; 104: 2774\u20138","DOI":"10.1038\/ajg.2009.417"},{"key":"10.3238\/arztebl.2014.0301_ref101","unstructured":"Zouboulis CC: Acne: Current aspects on pathology and treatment. Dermatol Experiences 1999; 1: 6\u201337."},{"key":"10.3238\/arztebl.2014.0301_ref102","doi-asserted-by":"crossref","unstructured":"Crockett SD, Porter CQ, Martin CF, et al.: Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol 2010; 105: 1986\u201393","DOI":"10.1038\/ajg.2010.124"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T10:55:12Z","timestamp":1693652112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,25]]},"references-count":102,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2014.0301","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,25]]}}}